This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
A Migraine Toolbox: A Practical Approach to Diagnosis and Treatment—Module 1: Diagnosis

A Migraine Toolbox: A Practical Approach to Diagnosis and Treatment—Module 1: Diagnosis

Format

Slide Lecture Series

Time to Complete

1 hour

Released

October 18, 2018

Expires

January 31, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / AMA PRA Category 1 CreditTM /AAFP Prescribed Credit
1.00 / CNE Contact Hour
1.00 / CE for Pharmacists (0.10 CEU)
1.00 / CDE Credits

Jointly Provided By

Jointly provided by Boston University School of Medicine and the Association of Migraine Disorders

CE for pharmacists is provided by the University of Rhode Island College of Pharmacy

In collaboration with



In collaboration with Brown Alpert Medical School Office of Continuing Medical Education.

Program Description

This module shares a methodology, including questionnaires, that will allow you to recognize migraine disease in its many presentations – all within the tight constraints of your busy medical setting. By the end of this learning module you will be aware of the international classification of headache disorders and the basic neurobiology of migraine disease. You will be able to identify acute and chronic migraine disorders - with and without aura.

Intended Audience

For any non-headache specialist healthcare professionals who encounter patients with migraine.

Educational Objectives

Upon completion of these activities, participants should be better able to:

  • Recall details about migraine disease prevalence
  • Define common migraine diagnostic criteria
  • Paraphrase the essential concepts of migraine pathophysiology
  • Describe a strategy for evaluating patients with migraine disease

Conflict Of Interest Disclosure Policy

The Boston University School of Medicine and the University of Rhode Island College of Pharmacy ask all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME), Continuing Nursing Education (CNE) and Continuing Pharmacy Education (CPE) activities to disclose all relevant relationships with commercial interests. This information is disclosed to CE activity participants prior to the start of the educational activity. Boston University School of Medicine and the University of Rhode Island College of Pharmacy have procedures to resolve any relevant conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Faculty

Frederick Godley, MD, FACS
ENT-Otolaryngologist
Providence, RI



Dr. Godley has disclosed that he is a member of the speaker’s bureau for Amgen.

PLANNERS AND REVIEWERS DISCLOSURES

Brian E. McGeeney, MD, MPH, CME Course Advisor is a consultant for Promius and Pernix and stockholder for Pfizer.
Marjorie Norquist, RN, MA, MPA, CNE Course Advisor has no relevant financial relationships to disclose.
Carmela Townsend, DNP, MS/MBA, RN, Lead Nurse Planner has no relevant financial relationships to disclose.
Paul George, MD, MHPE, Independent Reviewer has no relevant financial relationships to disclose.
Timothy Osborn, DDS, MS, FACS, CDE Advisor has no relevant financial relationships to disclose.
Dan Henry, MD, AAFP Reviewer receives grant support from Alder BioPharma, Lilly and Amgen.
Christopher A. Ferreira, MS, PA-C, Reviewer has no relevant financial relationships to disclose.
Julie Roth, MD, Reviewer has no relevant financial relationships to disclose.
Audrey Tyrka, MD, PhD, Reviewer has no relevant financial relationships to disclose.
Holly D. Webster, BSN, MS, Reviewer spouse receives consultation fees from Alcobra, Indivior, Insys, Kempharm, Pain Therapeutics, Pfizer, Shionogi and Teva and is an advisory board member for Daiichi Sankyo, Egalet and Inspirion.

Accredited Provider Disclosure

Joanna Krause, Grants Manager, and Julie White, Director of Boston University School of Medicine CME, Mary-Jane Kanaczet, Director Office of Continuing Professional Development at the University of Rhode Island College of Pharmacy, and Maria Sullivan, Director of Brown Alpert Medical School Office of Continuing Medical Education, have no relevant financial relationships to disclose.

Publishing Staff Disclosures

Ashley Barrett, Leigh Serth, and Alicia Torborg of Association of Migraine Disorders have no relevant financial relationships to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Association of Migraine Disorders. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Boston University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly-provided by Association of Migraine Disorders.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

Contact Hours: 1.0

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

A Migraine Toolbox: Module 1: Diagnosis

UAN 0060-9999-18-040-H01-P

1.0 Contact Hours (0.10 CEUs)

Credit

1.00

Type

CDE Credit

Accreditation Statement

Boston University Henry M. Goldman School of Dental Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

Designation Statement

Boston University Henry M. Goldman School of Dental Medicine designates this activity for 1.00 continuing education credit.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM
AAFP Prescribed Credit

Accreditation Statement

This Enduring Material activity, A Migraine Toolbox: A Practical Approach to Diagnosis and Treatment, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins 10/16/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Designation Statement

Boston University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Approved for 1.00 AAFP Prescribed credits.

Disclosure of Unlabeled Use

Faculty member does plan on discussing unlabeled/investigational uses of commercial products.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

Instructions for CME, CNE and CDE Continuing Education Credits

By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.00 AMA PRA Category 1 Credit, nurses are entitled to receive 1.00 CNE contact hours, and dentists are entitled to receive 1.00 CDE Credits. Statements of credit will be available to print immediately. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Successfully complete the post-test and activity evaluation.
  • You must score with a 70% or higher on the post-test to receive credit for this activity.
  • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

For any CME or CNE accreditation questions please email the BUSM CME office at cme@bu.edu.

Instructions for Completing a Program Evaluation and Reporting Pharmacy CE Credit

Program Evaluation
All participants will have the opportunity to evaluate the educational session, speakers and identify future educational needs.

Requirements for CE Credit
A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the program completion date in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.

Instructions for Completing a Program Evaluation and Reporting Pharmacy CE credit

1. Go to the University of Rhode Island College of Pharmacy Continuing Professional Development Learning Management System located at www.uripharmacycpd.org and create an account using your email address and pharmacy license number.* Enter all of the required account information. Verify that your date of birth and NABP ID Number are entered correctly. Click the “Update Account” button at the bottom of the page to save the account information.

2. Complete the program evaluations. Evaluations must be completed within 60 days of the program.
  • Participants in the online enduring activity should click on Available Online Activities and select the program title of the activity. Select post-test.
  • Enter the program evaluation code.
  • Complete the evaluation and click “submit.”
  • You will receive a confirmation message of evaluation completion and notification that your CE data was reported to the CPE Monitor.

The access code for this enduring program A Migraine Toolbox: A Practical Approach to Diagnosis and Treatment - Module I is MT36PA

Please note: ACPE will only accept CPE data that is reported by providers within 60 days of the live program date. CPE data is reported immediately upon your completion of this evaluation although it may take 48-72 hours to appear in your CPE Monitor profile. You will be notified of any problems transmitting your participant data via email. Most transmission problems are related to errors in transcribing date of birth and/or NABP ID number. It is strongly recommended that you check your profile in the CPE Monitor to verify your participation in this program has been reported.

*Your pharmacy license number, date of birth and NABP ID number are required to create an account in the URI CPD online registration and evaluation system in order to report participant data to the CPE Monitor. Pharmacy license numbers will not be used for any other purpose.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue